Avid Bioservices Inc (CDMO)

[cjgaddy]

Towards profitability: Q3(1-31-19) needed to cover $3.2M/G&A + $1.4M/Div = ~$4.7M expenses, but revs of $13.8M @ GM=15% only covered $2.1M of expenses, thus a net Loss of $2.6M.
If(when) we get to $16M revs at GM=30%, that would gen. GP of $4.8M and flip over to a net Profit for the qtr. And then, BAM!
Roger Lias 3-11-19 CC:
"All of this positions us well for growth and achieving profitability, which we believe is now within reach in the coming FY [FY2020: fye 4-30-20].

  
 AVID GROSS PROFITABILITY BY QTR:            DEFER          CUST 
 QTR  (1000’s)      Rev$  COGS$  Prof$  GP%   REV$ INVEN$   DEP. 
 FY13Q1  7-31-12   4,135  2,024  2,111  51%  6,056  5,744 10,224 
 FY13Q2 10-31-12   6,061  3,703  2,358  39%  6,221  5,426  8,500 
 FY13Q3  1-31-13   6,961  3,651  3,310  47%  5,061  4,635  6,729 
 FY13Q4  4-30-13   4,176  3,217    959  23%  4,171  4,339  8,059 
 FY14Q1  7-31-13   4,581  2,670  1,911  42%  4,164  5,679  8,528 
 FY14Q2 10-31-13   7,354  4,195  3,159  43%  3,468  4,033  7,658 
 FY14Q3  1-31-14   3,885  2,416  1,469  38%  4,329  5,224  8,646 
 FY14Q4  4-30-14   6,474  3,829  2,645  41%  5,241  5,530  5,760  
 FY15Q1  7-31-14   5,496  3,583  1,913  35%  4,670  5,998  6,226 
 FY15Q2 10-31-14   6,263  4,139  2,124  34%  3,612  5,379  7,549 
 FY15Q3  1-31-15   5,677  3,113  2,564  45%  5,752  6,148  8,311 
 FY15Q4  4-30-15   9,308  4,758  4,550  49%  6,630  7,354 11,363 
 FY16Q1  7-31-15   9,379  4,608  4,771  51%  8,291 10,457  9,599 
 FY16Q2 10-31-15   9,523  4,741  4,782  50%  9,688 12,554 14,935 
 FY16Q3  1-31-16   6,672  3,896  2,776  42% 15,418 15,189 22,433 
 FY16Q4  4-30-16  18,783  9,721  9,062  48% 15,418 15,189 24,212 
 FY17Q1  7-31-16   5,609  3,062  2,547  45% 21,531 25,274 21,731 
 FY17Q2 10-31-16  23,370 15,441  7,929  34% 17,980 25,924 26,928 
 FY17Q3  1-31-17  10,747  7,974  2,773  26% 26,367 33,829 26,210 
 FY17Q4  4-30-17  17,904 11,782  6,122  34% 28,500 33,099 17,017 
 FY18Q1  7-31-17  27,077 20,448  6,629  24% 13,433 24,235 14,322 
 FY18Q2 10-31-17  12,782 16,242 -3,460 -27%  7,473 16,518 13,138 
 FY18Q3  1-31-18   6,819 10,951 -4,132 -61%  6,633 14,218 17,602 
 FY18Q4  4-30-18   6,943  8,904 -1,961 -28% 10,922 16,129 17,013 
 FY19Q1  7-31-18  12,589 11,397  1,192   9% --,---  9,168 --,---* 
 FY19Q2 10-31-18  10,178  9,844    334   3% --,---  9,736 --,---* 
 FY19Q3  1-31-19  13,781 11,731   2050  15% --,---  8,660 --,---* 
 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147475461